Effects of Intravitreal Faricimab 6.0 mg Injection on Functional and Anatomic Outcomes in Patients with Neovascular Age-related Macular Degeneration

被引：0
|
作者：
Pandit, Saagar [1 ]
Wakabayashi, Taku [1 ]
Mansour, Hana [1 ]
Pashaee, Bahram [2 ]
Chiang, Allen [1 ]
Hsu, Jason [1 ]
机构：
[1] Wills Eye Hosp & Res Inst, Retina, Philadelphia, PA USA
[2] Thomas Jefferson Univ, Populat Hlth, Philadelphia, PA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2235
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Comparison between Aflibercept, Ranibizumab intravitreal injection on Neovascular Age-related macular degeneration patients
    Kwon, Y. H.
    Min, J. S.
    Ahn, H.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [22] Real-world efficacy of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review
    Nasimi, Nasratullah
    Nasimi, Safiullah
    Grauslund, Jakob
    Vergmann, Anna Stage
    Subhi, Yousif
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2024, 10 (01)
  • [23] Comparison between Aflibercept, Ranibizumab Intravitreal Injection on Neovascular Age-related Macular Degeneration Patients
    Min, Ji Sang
    Jung, Hyun Chul
    Suh, Ji Young
    Kwon, Yoon Hyung
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2016, 57 (11): : 1738 - 1744
  • [24] Intravitreal Bevacizumab Injection in Patients With Neovascular Age-Related Macular Degeneration and Low Visual Acuity
    El Matri, L.
    Bouraoui, R.
    Landolsi, H.
    Kort, F.
    Chebil, A.
    Limaiem, R.
    Mghaieth, F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [25] Changes in Macular Pigment Optical Density after Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration: A Pilot Study
    Cennamo, Gilda
    Rinaldi, Michele
    Chiosi, Flavia
    Costagliola, Ciro
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (16)
  • [26] Effects of Intravitreal Aflibercept on Neovascular Age-Related Macular Degeneration Resistant to Intravitreal Ranibizumab
    Suzuki, Katsuya
    Yasukawa, Tsutomu
    Kato, Aki
    Fujino, Shinpei
    Morita, Hiroshi
    Ota, Satoshi
    Hirahara, Shuichiro
    Munenori, Yoshida
    Ogura, Yuichiro
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [27] One-Year Real-World Outcomes of Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration
    Giuseppe Cancian
    Arianna Paris
    Lia Agliati
    Angelica Rizzato
    Michele Clerici
    Giulio Volpe
    Moreno Menghini
    Gabriela Grimaldi
    Ophthalmology and Therapy, 2024, 13 (11) : 2985 - 2997
  • [28] COST-EFFECTIVENESS OF FARICIMAB IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN CANADA
    Buhrer, C.
    Paulo, T.
    Diles, D.
    VALUE IN HEALTH, 2022, 25 (12) : S111 - S112
  • [29] Comparison of functional and morphologic changes between brolucizumab and faricimab in neovascular age-related macular degeneration
    Maiko Maruyama-Inoue
    Yasuo Yanagi
    Tatsuya Inoue
    Kazuaki Kadonosono
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2024, 262 : 589 - 599
  • [30] Comparison of functional and morphologic changes between brolucizumab and faricimab in neovascular age-related macular degeneration
    Maruyama-Inoue, Maiko
    Yanagi, Yasuo
    Inoue, Tatsuya
    Kadonosono, Kazuaki
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (02) : 589 - 599
12345